Clinical Trial Update: Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preoperative chemotherapy with pembrolizumab and low or high dose radiation in node-positive, triple-negative breast cancer; e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Node-positive Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer, Triple Negative Breast Cancer (TNBC) | Phase 2 | Status: NOT_YET_RECRUITING